Editorial: ¹⁸F-Fluoride PET/MR in cardiac amyloid; simple addition versus synergy?

Sarah A M Cuddy^{1

2}

Affiliations

¹ Cardiac Amyloidosis Program, Division of Cardiology, Department of Medicine, Brigham and Women's Hospital, Boston, USA. cuddy.sarah@gmail.com.
² CV Imaging Program, Cardiovascular Division and Department of Radiology, Brigham and Women's Hospital, Boston, USA. cuddy.sarah@gmail.com.

Editorial

Sarah A M Cuddy. J Nucl Cardiol. 2022 Apr.

. 2022 Apr;29(2):750-752.

doi: 10.1007/s12350-020-02437-1. Epub 2020 Nov 17.

Sarah A M Cuddy^{1

2}

¹ Cardiac Amyloidosis Program, Division of Cardiology, Department of Medicine, Brigham and Women's Hospital, Boston, USA. cuddy.sarah@gmail.com.
² CV Imaging Program, Cardiovascular Division and Department of Radiology, Brigham and Women's Hospital, Boston, USA. cuddy.sarah@gmail.com.

No abstract available

Comment on

18F-fluoride PET/MR in cardiac amyloid: A comparison study with aortic stenosis and age- and sex-matched controls.
Andrews JPM, Trivieri MG, Everett R, Spath N, MacNaught G, Moss AJ, Doris MK, Pawade T, van Beek EJR, Lucatelli C, Newby DE, Robson P, Fayad ZA, Dweck MR. Andrews JPM, et al. J Nucl Cardiol. 2022 Apr;29(2):741-749. doi: 10.1007/s12350-020-02356-1. Epub 2020 Sep 30. J Nucl Cardiol. 2022. PMID: 33000405 Free PMC article.

1. Gillmore JD, Maurer MS, Falk RH et al (2016) Nonbiopsy diagnosis of cardiac transthyretin amyloidosis. Circulation 133:2404-2412. https://doi.org/10.1161/CIRCULATIONAHA.116.021612 - DOI - PubMed
1. Joshi NV, Vesey AT, Williams MC et al (2014) ¹⁸F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: A prospective clinical trial. Lancet 383:705-713. https://doi.org/10.1016/S0140-6736(13)61754-7 - DOI - PubMed
1. Irkle A, Vesey AT, Lewis DY et al (2015) Identifying active vascular microcalcification by ¹⁸F-sodium fluoride positron emission tomography. Nat Commun. https://doi.org/10.1038/ncomms8495 - DOI - PubMed
1. Kwiecinski J, Tzolos E, Adamson PD et al (2020) Coronary ¹⁸F-sodium fluoride uptake predicts outcomes in patients with coronary artery disease. J Am CollCardiol 75:3061-3074. https://doi.org/10.1016/j.jacc.2020.04.046 - DOI
1. Morgenstern R, Yeh R, Castano A, Maurer MS, Bokhari S (2017) ¹⁸Fluorine sodium fluoride positron emission tomography, a potential biomarker of transthyretin cardiac amyloidosis. J Nucl Cardiol 2017:1-9. https://doi.org/10.1007/s12350-017-0799-x - DOI